What are the adverse reactions of levoketoconazole?
As an important drug for the treatment of Cushing's syndrome, levoketoconazole works by inhibiting cortisol synthase, but its adverse reaction spectrum needs to be fully understood by clinicians and patients. During treatment, the most common adverse reactions include gastrointestinal symptoms such as nausea and vomiting, abdominal pain, and indigestion; electrolyte imbalances, especially hypokalemia; and increased bleeding tendency (manifested by abnormal bruising or bleeding). These reactions are often associated with a broad inhibitory effect of the drug on adrenocortical hormone synthesis.
In terms of the endocrine system, about20% of patients experience high blood pressure fluctuations, which is related to the readjustment of hormone levels in the body. Liver toxicity is a problem that requires special vigilance. About 15% of patients experience elevated transaminases. Although most of them are mildly reversible, about 2-3% may develop severe liver damage. Abnormal uterine bleeding is common in female patients, while men may experience decreased testosterone levels. Other common reactions include headache, skin erythema, joint and muscle pain, and fatigue.

What deserves more attention is the serious adverse reactions that may be caused by levoketoconazole. Hypocortisolism manifests as profound fatigue, hypotension, and hypoglycemia, requiring prompt dose adjustment. Anaphylaxis, although rare, may manifest as a severe rash or anaphylactic shock. Regarding the heart, the risk of QT prolongation and arrhythmias is significantly increased when combined with hypokalemia. Long-term medication may also affect pituitary-adrenal axis function, leading to secondary adrenal insufficiency.
It is recommended to take the following preventive measures during clinical use: electrolyte imbalance must be corrected before treatment; liver function, electrolytes and electrocardiogram should be monitored regularly during treatment; female patients should pay attention to changes in menstrual cycles; serious adverse reactions should seek medical attention immediately. Most adverse reactions can be alleviated after dose adjustment, but abnormal liver function or severe cardiac arrhythmias may require permanent discontinuation of the drug. With appropriate monitoring and management, the therapeutic value of levoketoconazole can be maximized while controlling its potential risks.
Reference materials:https://en.wikipedia.org/wiki/Levoketoconazole
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)